An analysis of the sequence of the BAD gene among patients with maturity-onset diabetes of the young (MODY)

被引:1
|
作者
Antosik, Karolina [1 ]
Gnys, Piotr [2 ]
Jarosz-Chobot, Przemyslawa [3 ]
Mysliwiec, Malgorzata [4 ]
Szadkowska, Agnieszka [5 ]
Malecki, Maciej [6 ]
Mlynarski, Wojciech [5 ]
Borowiec, Maciej [1 ]
机构
[1] Med Univ Lodz, Dept Clin Genet, Pomorska 251, PL-92213 Lodz, Poland
[2] Medeor Plus Hosp, Lodz, Poland
[3] Silesian Med Univ Katowice, Dept Pediat Endocrinol & Diabet, Katowice, Poland
[4] Med Univ Gdansk, Dept Pediat Oncol Hematol & Endocrinol, Gdansk, Poland
[5] Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Lodz, Poland
[6] Jagiellonian Univ Krakow, Coll Med, Dept Metab Dis, Krakow, Poland
来源
关键词
BAD gene; GCK gene; GCK-MODY; monogenic diabetes; GLUCOKINASE; DEATH; LIVER;
D O I
10.1515/jpem-2016-0239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Monogenic diabetes is a rare disease caused by single gene mutations. Maturity onset diabetes of the young (MODY) is one of the major forms of monogenic diabetes recognised in the paediatric population. To date, 13 genes have been related to MODY development. The aim of the study was to analyse the sequence of the BCL2-associated agonist of cell death (BAD) gene in patients with clinical suspicion of GCK-MODY, but who were negative for glucokinase (GCK) gene mutations. Methods: A group of 122 diabetic patients were recruited from the "Polish Registry for Paediatric and Adolescent Diabetes-nationwide genetic screening for monogenic diabetes" project. The molecular testing was performed by Sanger sequencing. Results: A total of 10 sequence variants of the BAD gene were identified in 122 analysed diabetic patients. Conclusions: Among the analysed patients suspected of MODY, one possible pathogenic variant was identified in one patient; however, further confirmation is required for a certain identification.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 50 条
  • [1] Maturity-onset diabetes of the young (MODY)
    Meissner, T.
    Marquard, J.
    Schober, E.
    DIABETOLOGE, 2010, 6 (03): : 219 - 228
  • [2] MATURITY-ONSET DIABETES OF THE YOUNG (MODY)
    FAJANS, SS
    DIABETES-METABOLISM REVIEWS, 1989, 5 (07): : 579 - 606
  • [3] MODY (MATURITY-ONSET DIABETES OF THE YOUNG)
    ISER, G
    FRITSCHE, A
    EGGSTEIN, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (51-52) : 1985 - 1986
  • [4] Maturity-onset diabetes of the young (MODY)
    Bobadilla-Olaje G.F.
    Calleja-López J.R.T.
    Ruibal-Tavares E.
    Rivera-Rosas C.N.
    Aguilera-Duarte L.J.
    Radwaste Solutions, 2022, 89 (02): : 27 - 31
  • [5] Mutation analysis in maturity-onset diabetes of the young (MODY)
    Ellard, S
    Bulman, MP
    Frayling, TM
    Beards, FE
    Appleton, M
    Hattersley, AT
    JOURNAL OF MEDICAL GENETICS, 1997, 34 : SP15 - SP15
  • [6] Maturity-onset diabetes of the young (MODY): a time to
    Al-Kandari, Hessa
    Al-Abdulrazzaq, Dalia
    Davidsson, Lena
    Al-Mulla, Fahd
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (07): : 565 - 566
  • [7] DIAGNOSIS OF MATURITY-ONSET DIABETES OF THE YOUNG (MODY)
    ODAWARA, M
    YAMASHITA, K
    LANCET, 1995, 345 (8960): : 1313 - 1313
  • [8] Maturity-onset diabetes of the young (MODY): an update
    Anik, Ahmet
    Catli, Gonul
    Abaci, Ayhan
    Bober, Ece
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2015, 28 (3-4): : 251 - 263
  • [9] Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY)
    Diren, Ayca
    Demirci, Deniz Kanca
    Gul, Nurdan
    Karacanli, Burcin
    Baykut, Aykut
    Tutuncu, Yildiz
    Ozturk, Oguz
    Satman, Ilhan
    Yilmaz-aydogan, Hulya
    IN VIVO, 2022, 36 (05): : 2490 - 2504
  • [10] HIGH PREVALENCE OF MATURITY-ONSET DIABETES OF THE YOUNG (MODY) AMONG INDIANS
    MOHAN, V
    RAMACHANDRAN, A
    SNEHALATHA, C
    MOHAN, R
    BHARANI, G
    VISWANATHAN, M
    DIABETES CARE, 1985, 8 (04) : 371 - 374